Factors Associated With Readmissions Following Left Ventricular Assist Device Implantation

被引:0
|
作者
Eisenga, John B. [1 ,2 ,3 ]
Mccullough, Kyle A. [1 ,2 ]
Afzal, Aasim [1 ]
Dimaio, J. Michael [1 ,4 ]
Moubarak, Ghadi [1 ,2 ]
Milligan, Greg [1 ]
Kabra, Nitin [1 ]
Rusia, Akash [1 ]
Rawitscher, David A. [1 ]
George, Timothy J. [1 ]
机构
[1] Baylor Scott & White, Heart Hosp, Plano, TX USA
[2] Baylor Scott & White Res Inst, Dallas, TX USA
[3] Baylor Univ, Med Ctr, Dallas, TX USA
[4] Texas A&M Univ, Dept Biomed Engn, College Stn, TX USA
关键词
Heart failure; LVAD; NYHA; Outcomes; Readmission; HOSPITAL READMISSIONS; HEART-FAILURE; IMPACT;
D O I
10.1016/j.jss.2025.02.009
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction: While left ventricular device implantation has been shown to improve both survival and quality of life in patients with end stage heart failure, these patients have a high rate of readmissions to the hospital. The incidence and factors associated with readmission are poorly characterized in the destination therapy population. Methods: All patients who underwent HeartMate III left ventricular assist device therapy (LVAD) implantation at our facility from 2017 to 2023 were identified. Patients undergoing primary LVAD implantation were included. Primary outcome was readmission for any reason. Multivariable linear regression was utilized to identify predictors of readmissions. Results: From 2017 to 2023, 151 primary LVAD implantations were performed with 12 (8.0%) perioperative moralities (defined as index implant hospitalization mortality). The 139 remaining patients suffered 456 separate readmissions with a median follow-up of 590 (303-1002) ds and a total follow-up of 270.7 patient-ys for a rate of 1.7 readmissions per patient-y. The most common cause of readmission was heart failure exacerbation (27.0%), major infection (17.8%), and major bleeding (13.6%). Patients who were readmitted within 6 mos were more likely to have New York Heart Association class III or IV symptoms compared to those who had not been readmitted 39.1% versus 11.8% versus 15%, P = 0.0008. On multivariable linear regression, increasing body mass index (P = 0.02), increased preoperative bilirubin (P = 0.04), and increased follow-up time (P < 0.01) were predictive of the need for readmissions. Conclusions: Following LVAD implantation, readmissions within 6 mos of surgery are associated with worse functional status at 6 mos and 1 y postoperatively. Increased body mass index and preoperative bilirubin were associated with more frequent readmissions. (c) 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:202 / 208
页数:7
相关论文
共 50 条
  • [21] Hospital Readmissions After Left Ventricular Assist Device Implantation Are Associated With Poor Outcomes: A Single Center Experience
    Ashrith, G.
    Cordero-Reyes, A. M.
    Vivo, R. P.
    Orrego, C. M.
    Suarez, E. E.
    Elias, B.
    Loebe, M.
    Bruckner, B. A.
    Trachtenberg, B. H.
    Torre-Amione, G.
    Bhimaraj, A.
    Estep, J. D.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S198 - S198
  • [22] The Location of Intractable Ventricular Arrhythmias Following Left Ventricular Assist Device Implantation
    Garan, A. R.
    Whang, W.
    Topkara, V. K.
    Levine, A. P.
    Yuzefpolskaya, M.
    Colombo, P. C.
    Mancini, D. M.
    Takeda, K.
    Takayama, H.
    Naka, Y.
    Uriel, N.
    Jorde, U. P.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S44 - S45
  • [23] Predictors of Right Ventricular Assist Device Following Left Ventricular Assist Device Implantation: An Assessment of Scoring Systems
    Yang, J. A.
    Chan, E. V.
    Shulman, B. P.
    Koekert, M. S.
    Lumbao, D.
    Lippel, M. A.
    Uriel, N.
    Argenziano, M.
    Jorde, U. P.
    Naka, Y.
    Takayama, H.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S19 - S19
  • [24] A THICKENING IN TIME: TRANSIENT LEFT VENTRICULAR HYPERTROPHY FOLLOWING LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION
    Wu, Robby
    Rinde-Hoffman, Debbie
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 2574 - 2574
  • [25] Infectious complications following contemporary left ventricular assist device implantation
    Zhu, Toby
    Dufendach, Keith A.
    Hong, Yeahwa
    Thoma, Floyd W.
    Kilic, Arman
    JOURNAL OF CARDIAC SURGERY, 2022, 37 (08) : 2297 - 2306
  • [26] Frailty and Clinical Outcomes Following Left Ventricular Assist Device Implantation
    Uzun, H. G.
    Demir, E.
    Simsek, E.
    Capanoglu, T.
    Karapolat, H.
    Engin, C.
    Yagdi, T.
    Ozturk, P.
    Ozbaran, M.
    Nalbantgil, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S82 - S83
  • [27] Patterns and predictors of dyspnoea following left ventricular assist device implantation
    Faulkner, Kenneth M.
    Jurgens, Corrine Y.
    Denfeld, Quin E.
    Chien, Christopher, V
    Thompson, Jessica Harman
    Gelow, Jill M.
    Grady, Kathleen L.
    Lee, Christopher S.
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2022, 21 (07) : 724 - 731
  • [28] Neopterin Elevation and Survival Following Left Ventricular Assist Device Implantation
    Lander, M. M.
    Mercurio, M.
    Hanley-Yanez, K.
    Sharbaugh, M. S.
    Althouse, A. D.
    Simon, M. A.
    Teuteberg, J. J.
    Lagazzi, L.
    Sciortino, C. M.
    McTiernan, C.
    Kormos, R.
    McNamara, D. M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S93 - S94
  • [29] Kidney Function Trajectory Following Left Ventricular Assist Device Implantation
    Walther, Carl P.
    Benoit, Julia
    Lamba, Harveen
    Navaneethan, Sankar D.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 557 - 557
  • [30] Right Ventricular Assist Device Placement During Left Ventricular Assist Device Implantation Is Associated With Improved Survival
    Crespo-Diaz, Ruben
    Mudy, Karol
    Khan, Nadeem
    Samara, Michael
    Eckman, Peter M.
    Sun, Benjamin
    Hryniewicz, Katarzyna
    ASAIO JOURNAL, 2024, 70 (07) : 570 - 577